A PROSPECTIVE STUDY OF OCULAR TOXICITY IN PATIENTS RECEIVING ETHAMBUTOL IN A TERTIARY HEALTH CARE HOSPITAL IN KOLKATA, EASTERN INDIA.

Author:

Biswas Saikat1,Nanda Debajyoti2,Saha Suranjan3

Affiliation:

1. Junior resident(MOTR), Department of Ophthalmology,RG Kar Medical College and Hospital

2. Associate Professor, Department of Ophthalmology, RG Kar Medical College and Hospital.

3. Junior resident, Department of Ophthalmology,RG Kar Medical College and Hospital.

Abstract

BACKGROUND:India accounts highest burden of tuberculosis cases about 2.64millions with incidence of 193 in year 2019(WHO). India is among the largest countries to implement National Tuberculosis Elimination Program(previously known as RNTCP). This program provides now daily regimen to the patients,where patients have to take daily dosage of ethambutol according to the body weight category of patients along with others ATDs ,which is a cause of concern,particular with regard to the ocular toxicity of ethambutol.The present study was undertaken to explore the ocular toxicity in the newly diagnosed cases of tuberculosis patients registered under the program in terms of visual acuity,color vision,optic disc ndings,visual eld and IOP changes. :EarlyAIMS AND OBJECTIVES detection of ocular changes due to ethambutol toxicity and early stoppage of ethambutol from the further ocular damages. STUDY DESIGNS:Hospital based prospective observational study for approximately one year(April 2020 to March 2021) in a tertiary health care centre in Kolkata. Both eyes of 53 newly diagnosed tuberculosis patients were examined prior to start ATDs(including ethambutol),fourMETHODS: and eight weeks after initiation phases and anytime within eight weeks in case of sudden onset of ocular complaints.Visual acuity,color vision,optic disc ndings,eld of vision,IOP were noted,tabulated and analyzed. Out of 106 eyes in 53 patients, decrease in visualRESULTS: acuity was seen in 10eyes(9.43%) ,impairment in red-green color in 12eyes(11.32%),optic disc abnormalities in 6eyes(5.66%) and visual eld changes were seen in 8eyes(7.55%).The defects were bilateral in all cases.There were no signicant changes in IOP within 8weeks commencement of ethambutol therapy.The patients with ocular changes were advised to stop ethambutol and showed signicant improvement in vision on follow up later. In our study populations of 53 patients, 6patients (11.32%)were found with ocular changes due toCONCLUSION: ethambutol toxicity. So early detection of ocular changes due to ethambutol toxicity has great importance for its prevention.So baseline ophthalmological examination prior to start ethambutol and periodic follow up can prevent untoward irreversible vision loss due to ethambutol toxicity.

Publisher

World Wide Journals

Reference16 articles.

1. Place VA, Black H. New antituberculous agents: Laboratory and clinical studies. Ann N Y Acad Sci. 1966;135:681–709.

2. Inocencio FP, Castillo TR. Toxic optic neuropathy secondary to ethambutol. Philipp JOphthalmol. 1999;24:65–8.

3. World Health Organization. Ethambutol efficacy and toxicity: Literature review and recommendations for daily and intermittent dosage in children. Geneva: World Health Organization;

4. Adel A. Ophthalmological side-effects of ethambutol. Scand J Respir Dis Suppl. 1969;69:55–8.

5. Schild HS, Fox BC. Rapid-onset reversible ocular toxicity from ethambutol therapy. Am J Med. 1991;90:404–6.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3